Evidence map›Paper›PMID 10490654›Full record

ArticleMolecular and cellular biology1999

NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors.

D Li, V Desai-Yajnik, E Lo, M Schapira, R Abagyan, H H Samuels

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

D LiDivision of Molecular Endocrinology, Departments of Medicine and Pharmacology, Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, USA.
V Desai-Yajnik
E Lo
M Schapira
R Abagyan
H H Samuels
Laboratory of Molecular Genetics · PLNew York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
METABOLIC EFFECTS OF THYROID HORMONE IN CELL CULTURER01DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1986 to 2007
$6.0M
SHORT-TERM TRAINING: STUDENTS IN HEALTH PROFESSIONAL SCHT35DK007421 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RAMASAMY, RAVICHANDRAN · 1985 to 2023
$2.5M
Metabolic Effects of Thyroid HormoneR56DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 2009 to 2009
$211k
NUCLEAR RECEPTOR INTERACTING FACTORSF32DK009581 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LI, DANGSHENG · 1997 to 1999
–
METABOLIC EFFECTS OF THYROID HORMONER37DK016636 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAMUELS, HERBERT H · 1991 to 1998
–
NCI NIH HHS P30 CA016087NIDDK NIH HHS DK09581NIDDK NIH HHS DK16636NIDDK NIH HHS F32 DK009581NIDDK NIH HHS R01 DK016636NIDDK NIH HHS R56 DK016636NIDDK NIH HHS T35 DK007421NIGMS NIH HHS GM5541808
6 · The paper itself

Abstract

Many nuclear receptors are capable of recognizing similar DNA elements. The molecular event(s) underlying the functional specificities of these receptors (in regulating the expression of their native target genes) is a very important issue that remains poorly understood. Here we report the cloning and analysis of a novel nuclear receptor coactivator (designated NRIF3) that exhibits a distinct receptor specificity. Fluorescence microscopy shows that NRIF3 localizes to the cell nucleus. The yeast two-hybrid and/or in vitro binding assays indicated that NRIF3 specifically interacts with the thyroid hormone receptor (TR) and retinoid X receptor (RXR) in a ligand-dependent fashion but does not bind to the retinoic acid receptor, vitamin D receptor, progesterone receptor, glucocorticoid receptor, or estrogen receptor. Functional experiments showed that NRIF3 significantly potentiates TR- and RXR-mediated transactivation in vivo but has little effect on other examined nuclear receptors. Domain and mutagenesis analyses indicated that a novel C-terminal domain in NRIF3 plays an essential role in its specific interaction with liganded TR and RXR while the N-terminal LXXLL motif plays a minor role in allowing optimum interaction. Computer modeling and subsequent experimental analysis suggested that the C-terminal domain of NRIF3 directly mediates interaction with liganded receptors through an LXXIL (a variant of the canonical LXXLL) module while the other part of the NRIF3 protein may still play a role in conferring its receptor specificity. Identification of a coactivator with such a unique receptor specificity may provide new insight into the molecular mechanism(s) of receptor-mediated transcriptional activation as well as the functional specificities of nuclear receptors.

Indexed as

Transcriptional ActivationAmino Acid MotifsAmino Acid SequenceBase SequenceCell CompartmentationComputer SimulationGene LibraryHeLa CellsHumansModels, MolecularMolecular Sequence DataNuclear ProteinsProtein BindingProtein Structure, TertiaryReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidITGB3BP protein, humanNuclear ProteinsReceptors, Cytoplasmic and NuclearReceptors, Retinoic AcidReceptors, Thyroid HormoneRetinoid X ReceptorsTranscription Factors

Identifiers

PMID10490654
PMCPMC84712
OpenAlexW2166939597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.